Onconetix (ONCO) Fundamental Analysis: Revenue, Earnings & Valuation

5.98 / 10

Netural

The firm scores 6.0/10 on fundamentals. Asset‑MV and Profit‑MV are bullish, supporting asset quality and earnings, while Revenue‑MV and Income‑tax/Total‑profit are bearish, dragging performance. Overall, fundamentals are mixed, warranting a moderate investment stance.

Analysis Checks(6/10)

Revenue-MV

Value-2.95

Score1/3

Weight15.09%

1M Return5.44%

Inventory turnover ratio

Value1.70

Score2/3

Weight-1.11%

1M Return-0.56%

Gross profit margin (%)

Value77.62

Score0/3

Weight-8.78%

1M Return-5.42%

Profit-MV

Value0.68

Score2/3

Weight17.22%

1M Return6.36%

Income tax / Total profit (%)

Value-0.00

Score1/3

Weight0.42%

1M Return0.21%

Current assets turnover ratio

Value0.23

Score1/3

Weight-0.38%

1M Return-0.17%

Fixed assets turnover ratio

Value6.08

Score2/3

Weight0.02%

1M Return0.01%

Cost of sales ratio (%)

Value22.38

Score3/3

Weight9.10%

1M Return4.08%

Asset-MV

Value-0.55

Score3/3

Weight51.54%

1M Return15.70%

Cash-MV

Value0.03

Score2/3

Weight16.87%

1M Return6.19%

Is ONCO undervalued or overvalued?

ONCO scores 5.98/10 on fundamentals and holds a Fair valuation at present. Backed by its -122.40% ROE, -1720.98% net margin, -0.15 P/E ratio, 0.14 P/B ratio, and 99.09% earnings growth, these metrics solidify its Netural investment rating.